GNS Healthcare and Arvinas Enter into Neuroscience Drug Discovery Collaboration

SOMERVILLE, Mass., May 9, 2022 /PRNewswire/ — GNS Healthcare, the leader in the use of “Virtual Patients”, Causal AI and simulation technology for biopharmaceutical companies, today announced a collaboration with Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company…

Click here to view original post